Phil and teva pharmaceuticals launch new program to improve access to the digihaler® family of inhalers to support asthma management

San francisco--(business wire)--phil inc., a patient access platform company that revolutionizes life science product commercialization, today announced an agreement with teva pharmaceuticals that will make digihaler® products available for prescription using the philrx patient access platform. teva's digihaler system is the first and only smart inhaler system that can provide objective inhaler data to help patients and their doctors have informed treatment discussion in support of asthma manag.
TEVA Ratings Summary
TEVA Quant Ranking